BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1691280)

  • 1. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1.
    Cavanaugh KP; Gurwitz D; Cunningham DD; Bradshaw RA
    J Neurochem; 1990 May; 54(5):1735-43. PubMed ID: 1691280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin, a Key Driver of Pathological Inflammation in the Brain.
    Iannucci J; Grammas P
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptors in health and disease.
    Peach CJ; Edgington-Mitchell LE; Bunnett NW; Schmidt BL
    Physiol Rev; 2023 Jan; 103(1):717-785. PubMed ID: 35901239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer's Disease.
    Iannucci J; Renehan W; Grammas P
    Front Neurosci; 2020; 14():762. PubMed ID: 32792902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Complex Work of Proteases and Secretases in Wallerian Degeneration: Beyond Neuregulin-1.
    Pellegatta M; Taveggia C
    Front Cell Neurosci; 2019; 13():93. PubMed ID: 30949030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.
    Bedoui Y; Neal JW; Gasque P
    J Neuroimmune Pharmacol; 2018 Sep; 13(3):309-329. PubMed ID: 29909495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of human
    Yang Y; Xin X; Fu X; Xu D
    Oncol Lett; 2018 Apr; 15(4):4523-4530. PubMed ID: 29556291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models.
    Rajput PS; Lyden PD; Chen B; Lamb JA; Pereira B; Lamb A; Zhao L; Lei IF; Bai J
    Neuroscience; 2014 Dec; 281():229-40. PubMed ID: 25261684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
    Covacu R; Perez Estrada C; Arvidsson L; Svensson M; Brundin L
    J Neurosci; 2014 Aug; 34(35):11571-82. PubMed ID: 25164655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin Activation of Glial Cells through Protease-Activated Receptor 1.
    Greenidge AR; Hall KR; Hambleton IR; Thomas R; Monroe DM; Landis RC
    Patholog Res Int; 2013; 2013():314709. PubMed ID: 23431500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.
    Scarisbrick IA; Radulovic M; Burda JE; Larson N; Blaber SI; Giannini C; Blaber M; Vandell AG
    Biol Chem; 2012 Apr; 393(5):355-67. PubMed ID: 22505518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.
    Machado A; Herrera AJ; Venero JL; Santiago M; de Pablos RM; Villarán RF; Espinosa-Oliva AM; Argüelles S; Sarmiento M; Delgado-Cortés MJ; Mauriño R; Cano J
    ISRN Neurol; 2011; 2011():476158. PubMed ID: 22389821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.
    Griffiths MR; Gasque P; Neal JW
    Int J Inflam; 2010 Aug; 2010():151097. PubMed ID: 21152121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.
    Cannon JR; Hua Y; Richardson RJ; Xi G; Keep RF; Schallert T
    Behav Brain Res; 2007 Nov; 183(2):161-8. PubMed ID: 17629581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin inhibits aquaporin 4 expression through protein kinase C-dependent pathway in cultured astrocytes.
    Tang Y; Cai D; Chen Y
    J Mol Neurosci; 2007; 31(1):83-93. PubMed ID: 17416972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptors: regulation of neuronal function.
    Saito T; Bunnett NW
    Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma.
    Okamoto T; Nishibori M; Sawada K; Iwagaki H; Nakaya N; Jikuhara A; Tanaka N; Saeki K
    J Neural Transm (Vienna); 2001; 108(2):125-40. PubMed ID: 11314768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton.
    Mahajan VB; Pai KS; Lau A; Cunningham DD
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12062-7. PubMed ID: 11050237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
    Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
    J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of NMDA receptor function by the serine protease thrombin.
    Gingrich MB; Junge CE; Lyuboslavsky P; Traynelis SF
    J Neurosci; 2000 Jun; 20(12):4582-95. PubMed ID: 10844028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.